VR Logo

Divi's Laboratories: Board Meeting Intimation for Inter-Alia Considering And Approving The Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2021.


DIVIs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2022 inter alia to consider and approve Notice is hereby given that a meeting of Board of Directors of the Company is scheduled to be held on Friday February 04 2022 inter-alia to consider and approve the standalone and consolidated unaudited financial results for the quarter and nine months ended December 31 2021.As informed earlier pursuant to the Code of Conduct for Prevention of Insider Trading of the Company the Trading Window for dealing in securities of the Company has been closed for Designated Persons and their Immediate Relatives as well as Insiders covered under the Code from January 01 2022 till 48 hours after the declaration of Unaudited Financial Results for the quarter and nine months ended December 31 2021.

Click here to view PDF